Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  US Nuclear Corp.    UCLE

US NUCLEAR CORP.

(UCLE)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

US Nuclear Signs Agreement With China National Nuclear Corporation's Subsidiary

01/21/2020 | 08:31am EST

Los Angeles, CA, Jan. 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- US Nuclear Corp. (OTC: UCLE) has signed a “Cooperation Agreement” with Dalian Zhonghe Scientific and Technological Development Co., a subsidiary of China National Nuclear Corporation (CNNC), to design, build, and mass produce radiation detectors and systems for the growing China nuclear market. 

China is the world’s major builder of nuclear power plants, with 46 in operation, 15 under construction, and around 200 planned.  Each nuclear power plant requires about $8 million worth of radiation detection equipment.  Currently, around 80% of that radiation detection equipment is imported into China at a steep cost.  Importing is not favorable due to the high cost and because functionality has been customized for the country of origin and does not always fit local procedures, regulations, and language.  US Nuclear aims to solve this problem. 

Under this new cooperation agreement, US Nuclear will work with Dalian Zhonghe to design the perfect radiation detection systems for use in Chinese Nuclear Power Plants.  These systems are planned to be built at a factory in China to be cost-competitive.  Furthermore, this factory will be a new trading partner for US Nuclear, buying sub-assemblies and helping with any required exports to China. 

CNNC is the most important player in China’s applied nuclear technology field and is also the earliest company that can design, engineer, and manufacture such products.  Furthermore, CNNC is affiliated with China Isotope and Radiation Corporation (CIRC), the biggest nuclear medicine manufacturer in China.  The CIRC can be an excellent customer for US Nuclear and MIFTEC’s medical isotope generator business. 

Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com

CONTACT:

US Nuclear Corp. (OTCBB: UCLE)

Robert I. Goldstein, President, CEO, and Chairman

Rachel Boulds, Chief Financial Officer

(818) 883 7043

Email: info@usnuclearcorp.com

Primary Logo


© GlobeNewswire 2020
All news about US NUCLEAR CORP.
01/06US NUCLEAR CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/06US NUCLEAR : 2019 Convertible Debenture Now Fully Converted, Closed, and Flat
AQ
2020US Nuclear Corp. Discusses The Progress of Its MIFTEC Contract and Overhuff T..
NE
2020US Nuclear Corp. Announces Third Quarter 2020 Results
GL
2020US NUCLEAR : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020US NUCLEAR : and Grapheton Brain Implants to Help Immobilized Patients
AQ
2020US Nuclear and Grapheton Brain Implants to Help Immobilized Patients
GL
2020US NUCLEAR : Secures Its Position at Bioelectronics Startup Grapheton
AQ
2020US Nuclear Secures Its Position at Bioelectronics Startup Grapheton
GL
2020US NUCLEAR : Tritium Monitor Market Soars Due to Construction of $20+ Billion IT..
AQ
More news
Financials (USD)
Sales 2019 3,54 M - -
Net income 2019 -3,16 M - -
Net cash 2019 0,10 M - -
P/E ratio 2019 -4,28x
Yield 2019 -
Capitalization 7,41 M 7,41 M -
EV / Sales 2018 2,02x
EV / Sales 2019 3,85x
Nbr of Employees 20
Free-Float 48,4%
Chart US NUCLEAR CORP.
Duration : Period :
US Nuclear Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Robert I. Goldstein Chairman, President & Chief Executive Officer
Richard Landry COO & Director-Investor Relations
Rachel Boulds Chief Financial Officer & Secretary
Michael G. Hastings Director
Dell Williamson Director
Sector and Competitors